Variable | CL (n = 112) | BPS (n = 110) | P - value |
---|---|---|---|
Age (y) | 0.73*a | ||
20–39 | 35 | 33 | |
40–59 | 44 | 42 | |
60–79 | 33 | 35 | |
Sex, No. M/F | 60/52 | 59/51 | 0.99*b |
Systolic BP (mmHg) | 167.13 ± 31.47 | 166.87 ± 34.79 | 0.15*c |
Diastolic BP (mmHg) | 102.52 ± 25.46 | 103.24 ± 23.47 | 0.22*c |
Hypertension, No. | 82 | 84 | 0.59*b |
Hb (g/dL) | 12.14 ± 1.35 | 12.36 ± 1.12 | 0.15*c |
BUN (mg/dL) | 43.37 ± 15.31 | 42.83 ± 17.68 | 0.16*c |
eGFR (ml/min/1.73 m2) | 13.15 ± 3.43 | 13.45 ± 3.62 | 0.48*c |
Creatinine (mg/dL) | 10.71 ± 1.48 | 10.42 ± 1.32 | 0.27*c |
Dialysis duration with respective access (months) | 14.22 ± 7.35 | 14.68 ± 7.22 | 0.18*c |
Type dialysis, No. | 0.37*b | ||
Haemodialysis | 107 | 102 | |
Peritoneal dialysis | 5 | 8 | |
Ambulatory status | 0.47*a | ||
Normal walking | 103 | 98 | |
Walking with assistive devices | 9 | 12 | |
Completely restricted walking | 0 | 0 | |
ASA level | 0.94*a | ||
1 | 31 | 34 | |
2 | 47 | 40 | |
3 | 34 | 36 | |
BMD | −2.57 ± 0.34 | −2.49 ± 0.52 | 0.47*c |
BMI (kg/m2) | 24.71 ± 4.34 | 25.12 ± 4.61 | 0.36*c |
Personal history of VTEs | 16/112 | 18/110 | 0.67*b |
Family history of VTEs | 12/112 | 14/110 | 0.64*b |
Diabetes mellitus | |||
Duration, year | 19 (4–26) | 18 (5–24) | 0.14*c |
Type 2, No. | 27 | 29 | 0.70*b |
Insulin use, No. | 15 | 17 | 0.66*b |